AI Article Synopsis

  • * A systematic review of literature from 1993 to 2023 identified 19 relevant studies from an initial pool of 6,760 articles, encompassing a total of 1,502 patients with varying surgical backgrounds.
  • * Results showed that the percentage of patients achieving adequate prophylactic anti-Xa levels varied widely with different dosing methods, highlighting the need for potentially better individualized dosing strategies to prevent VTE events.

Article Abstract

Background: Patients undergoing surgical procedures are at an increased risk of venous thromboembolism events. A fixed Enoxaparin dosing regimen is the standard of care for chemoprophylaxis in most institutions; however, breakthrough venous thromboembolism events are still reported. We aimed to systematically review the literature to determine the ability of various Enoxaparin dosing regimens to achieve adequate prophylactic anti-Xa levels for venous thromboembolism prevention in hospitalized general surgery patients. Additionally, we aimed to assess the correlation between subprophylactic anti-Xa levels and the development of clinically significant venous thromboembolism events.

Methods: A systematic review was conducted using major databases from January 1, 1993, to February 17, 2023. Two independent researchers screened titles and abstracts, followed by a full-text review. Articles were included if Enoxaparin dosing regimens were evaluated by anti-Xa levels. Exclusion criteria included systematic reviews, pediatric population, nongeneral surgery (defined as trauma, orthopedics, plastics, and neurosurgery), and non-Enoxaparin chemoprophylaxis. The primary outcome was peak Anti-Xa level measured at steady state concentration. The risk of bias was assessed using the Risk of Bias in Nonrandomized studies-of Intervention tool.

Results: A total of 6,760 articles were extracted, of which 19 were included in the scoping review. Nine studies included bariatric patients, whereas 5 studies explored abdominal surgical oncology patients. Three studies assessed thoracic surgery patients, and 2 studies included patients undergoing "general surgery" procedures. A total of 1,502 patients were included. The mean age was 47 years, and 38% were males. The percentages of patients reaching adequate prophylactic anti-Xa levels were 39%, 61%, 15%, 50%, and 78% across the 40 mg daily, 40 mg twice daily, 30 mg twice daily, and weight-tiered, and body mass index-based groups, respectively. The overall risk of bias was low to moderate.

Conclusion: Fixed Enoxaparin dosing regimens are not correlated with adequate anti-Xa levels in general surgery patients. Additional research is warranted to assess the efficacy of dosing regimens based on novel physiologic parameters (such as estimated blood volume).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2023.04.032DOI Listing

Publication Analysis

Top Keywords

enoxaparin dosing
20
dosing regimens
20
anti-xa levels
20
surgery patients
16
venous thromboembolism
16
general surgery
12
risk bias
12
patients
10
systematic review
8
patients undergoing
8

Similar Publications

Article Synopsis
  • A study aimed to investigate the effects of Echinacea extract syrup on COVID-19 patients’ respiratory outcomes, given its known antiviral properties, despite limited evidence for its effectiveness against the virus.
  • The research involved a single-blind randomized controlled trial with 40 hospitalized COVID-19 patients split into two groups; one received Echinacea syrup in addition to standard treatment, while the other received standard treatment only.
  • Results showed a significant decrease in white blood cell counts in the group receiving Echinacea, but no significant differences in arterial oxygen pressure or lung involvement between the two groups after treatment.
View Article and Find Full Text PDF

Introduction: Chronic pulmonary aspergillosis (CPA) often develops in residual lesions of pulmonary tuberculosis (PTB). Every year, 112,000 to 160,000 people worldwide will develop post-PTB CPA. The simultaneous occurrence of CPA with the first episode of PTB is rare.

View Article and Find Full Text PDF

Objective: To assess the effectiveness and safety of low molecular weight heparins (LMWHs) on live birth rates and adverse pregnancy outcomes in individuals experiencing recurrent spontaneous abortion (RSA).

Data Sources: PubMed, Web of Science, the Cochrane Library, and Embase from database inception to July 1, 2024.

Study Eligibility Criteria: Eligible randomised controlled trials enrolled women with RSA who received LMWH, with a follow-up duration of at least 12 weeks.

View Article and Find Full Text PDF
Article Synopsis
  • Low molecular weight heparin (LMWH) is the standard for preventing blood clots after joint surgery, but its optimal dosing is not well established.
  • This study tested three enoxaparin dosing regimens in patients post-hip or knee replacement, focusing on thromboembolic events and safety indicators like bleeding.
  • Results showed similar thromboembolic rates across all groups, with the 40 mg dose given 12 hours after surgery having the least bruising and drainage, indicating it may be the safest option.
View Article and Find Full Text PDF

Determination of the optimal obesity-adjusted dosing weight for enoxaparin.

Br J Clin Pharmacol

November 2024

Department of Internal Medicine, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.

Aims: The ideal dosing weight metric for enoxaparin remains elusive. Dosing remains focused on actual body weight, which may inadvertently increase the risk of bleeding in those with obesity, or ideal weight, which may underdose those with obesity. Our aim was to determine the optimal obesity-adjusted enoxaparin dosing weight.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

A PHP Error was encountered

Severity: Notice

Message: fwrite(): Write of 34 bytes failed with errno=28 No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 272

Backtrace:

A PHP Error was encountered

Severity: Warning

Message: session_write_close(): Failed to write session data using user defined save handler. (session.save_path: /var/lib/php/sessions)

Filename: Unknown

Line Number: 0

Backtrace: